Target intelligence / Profile preview

Polyribosyl-ribitol-phosphate Capsule of Haemophilus influenzae Type b (PRP)

Target: PRP
Molecular classification: Polysaccharide, Capsular Polysaccharide

Overview

The polyribosyl-ribitol-phosphate (PRP) capsule is a polysaccharide structure that forms the outermost layer of encapsulated Haemophilus influenzae type b (Hib) bacteria. This capsule is a critical virulence factor, enabling the bacterium to evade host immune responses and cause invasive diseases. The PRP polysaccharide serves as the antigenic component used in all licensed Hib conjugate vaccines. These vaccines link purified or size-reduced PRP to carrier proteins to enhance immunogenicity, especially in infants.

Other names: Hib capsuleHaemophilus influenzae type b capsule

Mechanism of action

Antibodies bind to PRP, promoting opsonization and complement-mediated killing of Hib; Hib conjugate vaccines elicit an antibody response against PRP, providing protective immunity.

Biological functions

Immune evasionVirulence factorAntigen

Disease associations

MeningitisSepsisEpiglottitisSeptic arthritisHaemophilus influenzae type b infection

Safety considerations

Vaccine-related adverse reactions (rare)Ineffectiveness in individuals with impaired immune responses

Interacting drugs

Hib conjugate vaccines (e.g., PRP-T, PRP-D)

2 more in the full profile.

Biomarkers

Anti-PRP antibody titers (for vaccine efficacy)PRP levels in cerebrospinal fluid or blood (for diagnosis of Hib infection)

Beyond the preview

Go deeper on Polyribosyl-ribitol-phosphate Capsule of Haemophilus influenzae Type b (PRP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyribosyl-ribitol-phosphate Capsule of Haemophilus influenzae Type b (PRP).

Explore the full profile